Discover 2,262 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Francisco offers opportunities for individuals interested in taking part in paid studies as healthy volunteers, as well as those looking for studies for a specific medical condition. The city has a strong emphasis on cutting-edge research for conditions such as HIV/AIDS, oncology, kidney disease, PCOS, and endometriosis, among others. By participating, you can gain access to the latest healthcare innovations and contribute to pioneering medical progress.
Filter
2
Filter results
Results: 2,262
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
for
Sensorineural Hearing Loss, Bilateral
Location: San Francisco CA, Iowa City IA, Nashville TN
Sponsor: Eli Lilly and Company
Sex: All
Age: 0+
Code: NCT05821959
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
for
Persistent Corneal Epithelial Defect
Location: Petaluma CA, Torrance CA, Grand Junction CO,
Sponsor: Glaukos Corporation
Sex: All
Age: 2+
Code: NCT05966493
Phase 2, Recruiting
Effect of Fetal Aortic Valvuloplasty on Outcomes
for
Congenital Heart Disease, Aortic Valve Stenosis,
Location: San Francisco CA, Columbus OH, Toronto
Sponsor: Queen Silvia Children's Hospital, Gothenburg, Sweden
Sex: All
Age: 0
Code: NCT05386173
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Fremont CA, Stockton CA, Woodland CA, Elk Grove CA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT04566328
Phase 3, Recruiting
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: San Francisco CA, Oakland CA, Madera CA, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 21
Code: NCT06064097
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: San Francisco CA, Palo Alto CA, Woodland CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase 2, Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: Martinez CA, Mission Hills CA, South Pasadena CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase 3, Recruiting
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
for
Renal Cell Carcinoma
Location: San Francisco CA, Nashville TN, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07049926
Phase 1, Phase 2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase 2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase 2, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: San Francisco CA, Vallejo CA, Sacramento CA,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
Skin Flap Visible Light Spectroscopy (VLS) Oximetry for Monitoring Free-Flap Ischemia During Breast Reconstruction and Recovery
for
Ischemia
Location: Burlingame CA
Sponsor: Spectros Corporation
Sex: All
Age: 0+
Code: NCT01173133
Recruiting
Evaluation of the Optimal Transition Program
for
ESRD, Hemodialysis
Location: Oakland CA, Sacramento CA, Memphis TN
Sponsor: Satellite Healthcare
Sex: All
Age: 18+
Code: NCT04263233
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Oakland CA, Phoenix AZ, Vancouver, Aurora CO, Calgary,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT05995353
Phase 3, Recruiting
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
for
Methylmalonic Acidemia
Location: Palo Alto CA, Los Angeles CA, San Diego CA, Edmonton,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 1+
Code: NCT05295433
Phase 1, Phase 2, Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
for
Buccal Mucosa Squamous Cell Carcinoma,
Location: San Francisco CA, Palo Alto CA, San Jose CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT04333537
Phase 2, Phase 3, Recruiting
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
for
Castration-Resistant Prostatic Cancer, Metastasis
Location: San Francisco CA, Los Angeles CA, Orange CA, Seattle WA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06863272
Phase 1, Phase 2, Recruiting
A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
for
Diabetic Foot Ulcer
Location: San Francisco CA, Fresno CA, Sylmar CA, Los Angeles CA,